Efficacy Safety and Tolerability of Inclisiran in Patients With Homozygous Familial Hypercholesterolemia Results From the ORION5 Randomized Clinical Trial

Simple item page
dc.article.end-page362en
dc.article.start-page354en
dc.citation.doi10.1161/CIRCULATIONAHA.122.063460en
dc.contributor.authorFrederick Raalen
dc.contributor.authorR Dursten
dc.contributor.authorRan Bien
dc.contributor.authorZ Talloczyen
dc.contributor.authorP Maheuxen
dc.contributor.authorE et alen
dc.date.accessioned2025-01-23T10:12:29Z
dc.date.available2025-01-23T10:12:29Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn0009-7322en
dc.identifier.urihttps://hdl.handle.net/10539/43639
dc.journal.titleEfficacy Safety and Tolerability of Inclisiran in Patients With Homozygous Familial Hypercholesterolemia Results From the ORION5 Randomized Clinical Trialen
dc.journal.volume149en
dc.publisherLIPPINCOTT WILLIAMS & WILKINSen
dc.titleEfficacy Safety and Tolerability of Inclisiran in Patients With Homozygous Familial Hypercholesterolemia Results From the ORION5 Randomized Clinical Trialen
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
300.98 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download

Collections

Academic Wits Research Outputs (All submissions)